Stirling Products Lts - Animal Health Care Company
Stirling Products Limited (Stirling) is an animal healthcare company focused on the development and commercialisation of metabolic modifiers for a range of indications in international animal healthcare markets. Stirling is a public Australian company (ASX:STI) headquartered in Perth, Australia.
Stirling's lead pharmaceutical compound, R-salbutamol (also known as R-albuterol) is a highly purified version of salbutamol, a well-established drug that has been used in the treatment of human asthma for more than 25 years.
Stirling's three technology platforms for R-salbutamol are:
1. Growth agents in livestock
2. Treatment for obesity in companion animals (dogs and cats)
3. Treatment of respiratory disorders in horses (primarily heaves)
